Drug Profile
Research programme: neurodegenerative disorder therapeutics - Orion/The German Center for Neurodegenerative Diseases
Latest Information Update: 28 Apr 2020
Price :
$50
*
At a glance
- Originator Orion; The German Center for Neurodegenerative Diseases
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Neurodegenerative disorders
Most Recent Events
- 28 Apr 2020 No recent reports of development identified for research development in Neurodegenerative-disorders in Finland
- 28 Apr 2020 No recent reports of development identified for research development in Neurodegenerative-disorders in Germany
- 07 Mar 2016 Early research in Neurodegenerative disorders in Finland (unspecified route)